Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |